Scoop has an Ethical Paywall
Goserelin to remain available to NZers
Goserelin to remain available to NZers
People with prostate cancer and breast cancer will continue to have fully funded access to the hormonal treatment goserelin (Zoladex) following an agreement between Government drug-funding agency PHARMAC and pharmaceutical company AstraZeneca.
PHARMAC Medical Director Dr Peter Moodie says he is pleased that patients will continue to have access to the medicine following discussions between PHARMAC and AstraZeneca, while savings are maintained for taxpayers.
Both the one and three-month preparations of goserelin and leuprorelin will continue to be fully funded in the GnRH analogues therapeutic group.
Dr Moodie says the agreement with AstraZeneca is verbal, and subject to contracting and final approval.
[ends]
NZ Drug Foundation: Two New Studies Show A Concerning Increase In Drug Use And Availability
Emirates Team NZ: Emirates Team New Zealand Ranked #5 In Global Sports Technology Power List
Tātaki Auckland Unlimited: Discover The Treasures Of Tāmaki Makaurau - Making Māori Tourism Accessible To All
International Writers' Workshop NZ Inc: Ōtepoti Poets Top The Kathleen Grattan Prize For A Sequence Of Poems
NZ Amateur Sport Association: 22 Amendments Proposed For 2022 Act Lodged On 22 November
Auckland University of Technology: Reading Helps Children Face A Difficult Future